AMRI Announces First Quarter 2017 Results

Go back to AMRI Announces First Quarter 2017 Results

Albany Molecular Research (AMRI) Tops Q1 EPS by 1c

May 9, 2017 7:31 AM EDT

Albany Molecular Research (NASDAQ: AMRI) reported Q1 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $163.8 million versus the consensus estimate of $161.45 million.

For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.

... More